輸入代號或公司名稱後按 Enter
VNDA

Vanda Pharmaceuticals Inc.

+0.14 (+2.90%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 生技醫療 · Pharmaceutical Preparations
5.15USD217K成交股數311M市值本益比(近四季)1.4股價營收比-3.9%營收年增(近四季)2026-11-04下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收50.5M+1%51.7M-3%56.3M+18%52.6M+4%50.0M+5%53.2M+37%47.7M+3%50.5M-19%47.5M38.8M46.1M62.5M
營業成本3.6M3.2M3.0M2.7M3.5M2.6M2.6M2.7M3.4M3.1M3.5M4.8M
毛利47.0M+1%48.6M-4%53.3M+18%49.9M+4%46.5M+6%50.6M+42%45.1M+6%47.7M-17%44.0M35.8M42.6M57.7M
毛利率93.0%93.9%94.7%94.8%93.0%95.1%94.6%94.6%92.8%92.1%92.4%92.4%
研發費用37.0M28.4M22.6M22.0M35.7M19.8M16.8M16.7M21.2M16.6M16.6M19.2M
銷售管理費用71.8M68.4M60.3M64.6M50.1M39.3M37.6M39.5M30.1M24.8M28.4M36.1M
營業利益−63.8M+56%−50.2M+389%−31.3M+184%−38.5M+279%−41.0M+344%−10.3M+71%−11.0M+284%−10.1M-606%−9.2M−6.0M−2.9M2.0M
營業利益率-126.3%-97.1%-55.6%-73.2%-82.0%-19.3%-23.1%-20.1%-19.5%-15.4%-6.2%3.2%
稅後淨利−62.5M+112%−48.6M+889%−22.6M+324%−27.2M+502%−29.5M+611%−4.9M-3685%−5.3M-450%−4.5M-239%−4.1M137K1.5M3.3M
淨利率-123.7%-93.9%-40.1%-51.7%-58.9%-9.2%-11.2%-9.0%-8.7%0.4%3.3%5.2%
稀釋 EPS-1.04+108%-0.82+811%-0.38+322%-0.46+475%-0.50+614%-0.09-0.09-400%-0.08-233%-0.070.000.030.06
稀釋股數60.2M59.5M59.1M59.0M58.5M58.1M58.3M58.2M57.8M57.6M57.5M57.4M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金55.9M54.0M70.0M81.0M112M102M100M103M125M183M150M354M
應收帳款59.7M56.9M50.5M45.0M44.6M47.1M42.8M41.9M36.7M29.3M33.6M24.5M
存貨1.7M1.7M2.0M2.2M1.9M1.7M1.6M1.5M1.5M1.0M1.1M1.1M
總資產412M434M601M625M632M656M645M651M653M642M642M645M
有息負債
總負債192M153M135M138M121M118M104M109M109M98.5M102M109M
股東權益220M281M466M486M511M539M541M543M544M543M540M536M
負債比46.6%35.2%22.5%22.2%19.1%17.9%16.1%16.7%16.7%15.4%15.9%16.9%
淨現金(現金 − 有息負債)

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流−50.2M−33.1M-538%7.6M31.8M
資本支出221K436K7K51K
自由現金流−50.4M−33.6M-544%7.6M31.8M
折舊攤銷
買回庫藏股
現金股利
自由現金流率-97.5%-67.1%15.9%50.8%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 216M
產品216M100.0%+8.7%
產品/服務2025 年度 · 216M
Fanapt117M54.3%+24.4%
Hetlioz71.4M33.1%-6.8%
PONVORY27.4M12.7%-1.5%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025216M+8.7%−221M-102.0%-3.74−110M
FY2024199M+3.2%−18.9M-9.5%-0.33−16.2M
FY2023193M-24.3%2.5M1.3%0.0412.4M
FY2022254M-5.3%6.3M2.5%0.1131.3M
FY2021269M+8.3%33.2M12.4%0.5863.7M
FY2020248M+9.2%23.3M9.4%0.4250.0M
FY2019227M+17.6%116M50.9%2.1144.9M
FY2018193M25.2M13.1%0.4829.6M